Director/PDMR Shareholding

May 02, 2017

The Company has received notification from Vulpes Life Sciences Fund ("Vulpes") that on 27 April 2017 it purchased 100,000 ordinary shares of 1p each in the capital of the Company ("Ordinary Shares") at a price of 5p per Ordinary Share (the “Purchase”). Following the Purchase Vulpes has a total direct and indirect interest in 54,043,715 equivalent to 18.34% of Proteome Sciences' total issued share capital.

Back to News